These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29954738)

  • 1. Inhibition of SNAT5 Induces Incretin-Responsive State From Incretin-Unresponsive State in Pancreatic β-Cells: Study of β-Cell Spheroid Clusters as a Model.
    Hashim M; Yokoi N; Takahashi H; Gheni G; Okechi OS; Hayami T; Murao N; Hidaka S; Minami K; Mizoguchi A; Seino S
    Diabetes; 2018 Sep; 67(9):1795-1806. PubMed ID: 29954738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion.
    Murao N; Yokoi N; Honda K; Han G; Hayami T; Gheni G; Takahashi H; Minami K; Seino S
    PLoS One; 2017; 12(11):e0187213. PubMed ID: 29091932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
    Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
    Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin-induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat.
    Hayami T; Yokoi N; Yamaguchi T; Honda K; Murao N; Takahashi H; Wang S; Seino Y; Kamiya H; Yabe D; Sweet IR; Mizoguchi A; Nakamura J; Seino S
    J Diabetes Investig; 2020 Nov; 11(6):1434-1447. PubMed ID: 32279428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.
    Gheni G; Ogura M; Iwasaki M; Yokoi N; Minami K; Nakayama Y; Harada K; Hastoy B; Wu X; Takahashi H; Kimura K; Matsubara T; Hoshikawa R; Hatano N; Sugawara K; Shibasaki T; Inagaki N; Bamba T; Mizoguchi A; Fukusaki E; Rorsman P; Seino S
    Cell Rep; 2014 Oct; 9(2):661-73. PubMed ID: 25373904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells.
    Amisten S; Mohammad Al-Amily I; Soni A; Hawkes R; Atanes P; Persaud SJ; Rorsman P; Salehi A
    Endocr J; 2017 Mar; 64(3):325-338. PubMed ID: 28228611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Cell glutamate signaling: Its role in incretin-induced insulin secretion.
    Yokoi N; Gheni G; Takahashi H; Seino S
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):38-43. PubMed ID: 27186354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
    Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB
    Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice.
    Cox AR; Lam CJ; Rankin MM; Rios JS; Chavez J; Bonnyman CW; King KB; Wells RA; Anthony D; Tu JX; Kim JJ; Li C; Kushner JA
    Endocrinology; 2017 Jun; 158(6):1701-1714. PubMed ID: 28323942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/cyclic adenosine monophosphate signaling.
    Iwasaki M; Minami K; Shibasaki T; Miki T; Miyazaki J; Seino S
    J Diabetes Investig; 2010 Aug; 1(4):137-42. PubMed ID: 24843422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exciting Times for Pancreatic Islets: Glutamate Signaling in Endocrine Cells.
    Otter S; Lammert E
    Trends Endocrinol Metab; 2016 Mar; 27(3):177-188. PubMed ID: 26740469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity.
    Mezghenna K; Pomiès P; Chalançon A; Castex F; Leroy J; Niclauss N; Nadal B; Cambier L; Cazevieille C; Petit P; Gomis R; Berney T; Gross R; Lajoix AD
    Diabetologia; 2011 Nov; 54(11):2856-66. PubMed ID: 21847584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.
    Maffei A; Segal AM; Alvarez-Perez JC; Garcia-Ocaña A; Harris PE
    Mol Endocrinol; 2015 Apr; 29(4):542-57. PubMed ID: 25751312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy.
    Seino S; Sugawara K; Yokoi N; Takahashi H
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():22-29. PubMed ID: 28880474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.
    Matsuda T; Takahashi H; Mieda Y; Shimizu S; Kawamoto T; Matsuura Y; Takai T; Suzuki E; Kanno A; Koyanagi-Kimura M; Asahara S; Bartolome A; Yokoi N; Inoue H; Ogawa W; Seino S; Kido Y
    PLoS One; 2015; 10(6):e0130757. PubMed ID: 26091000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-A downregulation improves insulin secretion in mice.
    Bonal CB; Baronnier DE; Pot C; Benkhoucha M; Schwab ME; Lalive PH; Herrera PL
    Diabetes; 2013 May; 62(5):1443-52. PubMed ID: 23274909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes.
    Kirk RK; Pyke C; von Herrath MG; Hasselby JP; Pedersen L; Mortensen PG; Knudsen LB; Coppieters K
    Diabetes Obes Metab; 2017 May; 19(5):705-712. PubMed ID: 28094469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.